SciELO - Scientific Electronic Library Online

1. Walboomers JMM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 1999, 51: 268¾275.

2. Ferlay J et al. Globocan 2000. Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon, International Agency for Research on Cancer, 2001 (IARC Cancer Base No. 5).

3. Coleman M et al. Time trends in cancer incidence and mortality. Lyon, International Agency for Research on Cancer, 1995 (IARC Scientific Publications No. 121).

4. Wabinga H et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960¾1997. British Journal of Cancer, 2000, 82: 585¾1592.

5. Hakama M et al. Evaluation of screening programmes for gynaecological cancer. British Journal of Cancer, 1985, 52: 669¾673.

6. Control of cancer of the uterine cervix. A WHO meeting. Bulletin of the World Health Organization, 1986, 64: 607¾618.

7. Hakama M et al. Screening for cancer of the uterine cervix. Lyon, International Agency for Research on Cancer, 1986 (IARC Scientific Publications No. 76).

8. Miller AB et al. Report on a workshop UICC project on evaluation of screening for cancer. International Journal of Cancer, 1990, 46: 761¾769.

9. Nasiell K et al. Behaviour of mild dysplasia during long-term follow-up. Obstetrics and Gynaecology, 1986, 67: 665¾669.

10. Holowaty P et al. Natural history of dysplasia of the uterine cervix. Journal of the National Cancer Institute, 1999, 91: 252¾ 268.

11. Fahey MT et al. Meta-analysis of Pap test accuracy. American Journal of Epidemiology, 1995, 141: 680¾689.

12. Nanda K et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine, 2000, 132: 810¾819.

13. Herdman C et al. Planning appropriate cervical cancer prevention programs. Seattle, WA, Program for Appropriate Technology in Health, 2000.

14. Irwin IR et al. Screening practices for cervical and breast cancer in Costa Rica. Bulletin of the Pan American Health Organization, 1991, 25: 16¾26.

15. Herrero R et al. Determinants of geographical variations of cervical cancer in Costa Rica. Bulletin of the Pan American Health Organization, 1993, 27: 15¾25.

16. Sierra R et al. Cancer in Costa Rica. Lyon, International Agency for Research on Cancer, 1988 (IARC Technical Report No. 1).

17. Schiffman et al. HPV DNA testing in cervical cancer screening: results from women in high-risk province of Costa Rica. Journal of the American Medical Association, 2000, 283: 87¾93.

18. Fernandez Garrotte L. Evaluation of the Cervical Cancer Control Program in Cuba. Bulletin of the Pan American Health Organization, 1996, 30, 387¾391.

19. Lazcano-Ponce EC et al. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control, 1998, 9: 241¾ 251.

20. Lazcano-Ponce EC et al. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Archives of Medical Research, 1999, 30: 240¾250.

21. Lazcano-Ponce EC et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytologica, 1997, 41: 277¾284.

22. Lazcano-Ponce EC et al. Mortality from cervical carcinoma in Mexico: impact of screening, 1980¾1990. Acta Cytologica, 1996, 40: 506¾512.

23. Chokunonga E et al. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993¾1995. International Journal of Cancer, 2000, 85: 54¾ 59.

24. University of Zimbabwe/JHPIEGO Cervical cancer prevention project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet, 1999, 353: 869¾873.

25. Womack SD et al. Evaluation of human papillomavirus assay in cervical screening in Zimbabwe. British Journal of Obstetrics and Gynaecology, 2000, 107: 33¾38.

26. Womack SD et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. International Journal of Cancer, 2000, 85: 206¾210.

27. Blumenthal PD et al. Adjunctive testing for cervical cancer in low- resource settings with visual inspection, HPV, and the Pap smear. International Journal of Gynecology and Obstetrics, 2001, 72: 47¾53.

28. Leiman G. "Project Screen Soweto" ¾ a planned cervical screening programme in a high-risk population. South African Medical Journal, 1987, 2: 61¾68.

29. Denny et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer, 2000, 89: 826¾ 833.

30. Wright TC et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Journal of the American Medical Association, 2000, 283: 81¾86.

31. Megevand E et al. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstetrics and Gynecology, 1996, 88: 383¾386.

32. Goldie SJ et al. Policy analysis of cervical cancer screening strategies in low-resource settings. Clinical benefits and cost effectiveness. Journal of the American Medical Association, 2001, 285: 3107¾3115.

33. Jayant K et al. Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. International Journal of Cancer, 1995, 63: 161¾163.

34. Jayant K et al. Survival from cancer in Barshi registry, rural India. In: Sankaranarayanan R, Black RJ, Parkin DM, eds. Cancer survival in developing countries. Lyon, International Agency for Research on Cancer, 1988: 69¾77 (IARC Scientific Publications No. 145).

35. Parkin DM, Sankaranarayanan R. Prevention of cervical cancer in developing countries. Thai Journal of Obstetrics and Gynaecology, 1999, 11S: 3¾20.

36. Sankaranarayanan R et al. Visual inspection as a screening test for cervical cancer control in developing countries. In: Franco E, Monsonego J, eds. New developments in cervical cancer screening and prevention. Oxford, Blackwell Science, 1997: 411¾421.

37. Sankaranarayanan R et al. Performance of visual inspection after acetic acid application (VIA) in the detection of cervical cancer precursors. Cancer, 1998, 83: 2150¾2156.

38. Sankaranarayanan R et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. International Journal of Cancer, 1999, 80: 161¾163.

39. National workshop on control of cervical cancer- alternative strategies. New Delhi, Institute of Cytology and Preventive Oncology, Indian Council of Medical Research, 2001.

40. Hakama M et al., eds. Screening for cancer of the uterine cervix. Lyon, International Agency for Research on Cancer, 1986 (IARC Scientific Publications No. 76).

41. Prabhakar AK. Cervical cancer in India strategy for control. Indian Journal of Cancer, 1992, 104: 29¾32.

42. Murthy NS et al. Estimation of reduction in life-time risk of cervical cancer through one life-time screening. Neoplasma, 1993, 40: 255¾258.

43. Miller AB. Cervical cancer screening programmes ¾ Managerial guidelines. Geneva, World Health Organization, 1992.